{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:02:34Z","timestamp":1785862954426,"version":"3.56.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.jcrs.2006.04.014","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T18:15:54Z","timestamp":1156529754000},"page":"1499-1502","source":"Crossref","is-referenced-by-count":13,"title":["Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy"],"prefix":"10.1097","volume":"32","author":[{"given":"Mustafa","family":"\u00dcnal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130clal","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20210210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3928\/1542-8877-20000701-09","article-title":"Effect of 0.2 brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.","volume":"31","author":"Seong","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"R2-36-20210210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0161-6420(85)34026-5","article-title":"Early complications following Q-switched neodymium:YAG laser posterior capsulotomy.","volume":"92","author":"Flohr","year":"1985","journal-title":"Ophthalmology"},{"key":"R3-36-20210210","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archopht.1984.01040030826025","article-title":"Intraocular pressure changes after neodymium-YAG laser posterior capsulotomy.","volume":"102","author":"Channell","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R4-36-20210210","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/eye.1996.111","article-title":"Effect of intraocular lens fixation on acute intraocular pressure rise after neodymium-YAG laser capsulotomy.","volume":"10","author":"Anand","year":"1996","journal-title":"Eye"},{"key":"R6-36-20210210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jcrs.2005.02.035","article-title":"Brimonidine 0.15 versus apraclonidine 0.5 for prevention of intraocular pressure elevation after anterior segment laser surgery.","volume":"31","author":"Chen","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"R7-36-20210210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0161-6420(01)00545-0","article-title":"Brimonidine 0.2 versus apraclonidine 0.5 for prevention of intraocular pressure elevations after anterior segment laser surgery.","volume":"108","author":"Chen","year":"2001","journal-title":"Ophthalmology"},{"issue":"suppl 2","key":"R8-36-20210210","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0039-6257(99)00108-3","article-title":"Preclinical overview of brinzolamide.","volume":"44","author":"DeSantis","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"R9-36-20210210","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs; a meta-analysis of randomized clinical trials.","volume":"112","author":"van der Valk","year":"2005","journal-title":"Ophthalmology"},{"key":"R10-36-20210210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9394(98)00095-6","article-title":"Clinical efficacy and safety of brinzolamide (Azopttm), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension; the Brinzolamide Primary Therapy Study Group.","volume":"126","author":"Silver","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R11-36-20210210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0002-9394(99)00343-8","article-title":"The long-term safety and efficacy of brinzolamide 1.0 (Azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.","volume":"129","author":"March","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R12-36-20210210","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcrs.2004.07.024","article-title":"Medical control of intraocular pressure after phacoemulsification.","volume":"31","author":"Dayanir","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"R13-36-20210210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.eye.6701470","article-title":"Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.","volume":"19","author":"Ermis","year":"2005","journal-title":"Eye"},{"key":"R14-36-20210210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0002-9394(14)76242-7","article-title":"Cystoid macular edema, retinal detachment, and glaucoma after Nd:YAG laser posterior capsulotomy.","volume":"112","author":"Steinert","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R15-36-20210210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3928\/1542-8877-19990301-08","article-title":"Apraclonidine 0.5 versus brimonidine 0.2 for the control of intraocular pressure elevation following anterior segment laser procedures.","volume":"30","author":"Chevrier","year":"1999","journal-title":"Ophthalmic Surg Lasers"},{"key":"R16-36-20210210","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archopht.1997.01100160411003","article-title":"Topical 2.0 dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.","volume":"115","author":"Ladas","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R17-36-20210210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bjo.77.3.136","article-title":"Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy.","volume":"77","author":"Ladas","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"R18-36-20210210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1076\/ceyr.25.4.237.13484","article-title":"Dorzolamide apraclonidine in the prevention of the intraocular pressure spike after Nd:YAG laser posterior capsulotomy.","volume":"25","author":"Arieta","year":"2002","journal-title":"Curr Eye Res"},{"key":"R20-36-20210210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0161-6420(88)33124-6","article-title":"Prophylactic treatment of intraocular pressure elevations after neodymium:YAG laser posterior capsulotomies and extracapsular cataract extractions with levobunolol.","volume":"95","author":"Silverstone","year":"1988","journal-title":"Ophthalmology"},{"key":"R21-36-20210210","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3928\/1542-8877-19950901-07","article-title":"Follow-up of argon laser trabeculoplasty: is a day-one postoperative IOP check necessary?","volume":"26","author":"Mittra","year":"1995","journal-title":"Ophthalmic Surg Lasers"},{"key":"R23-36-20210210","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/archopht.1988.01060130824031","article-title":"Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1 apraclonidine.","volume":"106","author":"Pollack","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R24-36-20210210","first-page":"623","article-title":"The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy.","volume":"24","author":"Cullom","year":"1993","journal-title":"Ophthalmic Surg"},{"key":"R25-36-20210210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9394(14)76162-8","article-title":"Prophylactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies.","volume":"113","author":"Silverstone","year":"1992","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335006006651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335006006651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.jcrs.2006.04.014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:01:24Z","timestamp":1785859284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02158034-200609000-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2006.04.014","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}